110 related articles for article (PubMed ID: 37264529)
1. Correction for: Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
Yang C; Li Q; Chen X; Zhang Z; Mou Z; Ye F; Jin S; Jun X; Tang F; Jiang H
Aging (Albany NY); 2023 May; 15(10):4563-4565. PubMed ID: 37264529
[No Abstract] [Full Text] [Related]
2. Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
Yang C; Li Q; Chen X; Zhang Z; Mou Z; Ye F; Jin S; Jun X; Tang F; Jiang H
Aging (Albany NY); 2020 Apr; 12(8):6865-6879. PubMed ID: 32305958
[TBL] [Abstract][Full Text] [Related]
3. TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.
Jiang CF; Xie YX; Qian YC; Wang M; Liu LZ; Shu YQ; Bai XM; Jiang BH
Cancer Cell Int; 2021 Oct; 21(1):542. PubMed ID: 34663310
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
Int J Cancer; 2019 Oct; 145(8):2170-2181. PubMed ID: 30939216
[TBL] [Abstract][Full Text] [Related]
5. KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway.
Guo J; Zhang W; Sun L; Yu H; Wang Y; Feng L; Yang H
Sci Rep; 2023 May; 13(1):7288. PubMed ID: 37142638
[TBL] [Abstract][Full Text] [Related]
6. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q
Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
Lu Q; Liu T; Feng H; Yang R; Zhao X; Chen W; Jiang B; Qin H; Guo X; Liu M; Li L; Guo H
Mol Cancer; 2019 Jun; 18(1):111. PubMed ID: 31228937
[TBL] [Abstract][Full Text] [Related]
8. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
[TBL] [Abstract][Full Text] [Related]
9. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circRIMS1 Acts as a Sponge of miR-433-3p to Promote Bladder Cancer Progression by Regulating CCAR1 Expression.
Wang F; Fan M; Cai Y; Zhou X; Tai S; Yu Y; Wu H; Zhang Y; Liu J; Huang S; He N; Hu Z; Jin X
Mol Ther Nucleic Acids; 2020 Dec; 22():815-831. PubMed ID: 33230478
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression.
Shi YR; Wu Z; Xiong K; Liao QJ; Ye X; Yang P; Zu XB
Front Pharmacol; 2020; 11():605. PubMed ID: 32457613
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis.
Wu S; Yang J; Xu H; Wang X; Zhang R; Lu W; Yang J; Li X; Chen S; Zou Y; Nan A
Cell Biol Toxicol; 2022 Feb; 38(1):129-146. PubMed ID: 33656636
[TBL] [Abstract][Full Text] [Related]
13. KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p.
Gan H; Lin L; Hu N; Yang Y; Gao Y; Pei Y; Chen K; Sun B
Cell Biochem Funct; 2019 Aug; 37(6):424-431. PubMed ID: 31328811
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
Liu P; Li X; Guo X; Chen J; Li C; Chen M; Liu L; Zhang X; Zu X
Cell Prolif; 2019 Jul; 52(4):e12614. PubMed ID: 30983072
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.
Yang C; Mou Z; Zhang Z; Wu S; Zhou Q; Chen Y; Gong J; Xu C; Ou Y; Chen X; Dai X; Jiang H
Mol Ther Nucleic Acids; 2021 Mar; 23():872-886. PubMed ID: 33614236
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
[TBL] [Abstract][Full Text] [Related]
17. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway.
Su Y; Feng W; Shi J; Chen L; Huang J; Lin T
Mol Cancer; 2020 Feb; 19(1):23. PubMed ID: 32019579
[TBL] [Abstract][Full Text] [Related]
18. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
19. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.
Bi J; Liu H; Cai Z; Dong W; Jiang N; Yang M; Huang J; Lin T
Aging (Albany NY); 2018 Aug; 10(8):1964-1976. PubMed ID: 30103209
[TBL] [Abstract][Full Text] [Related]
20. Correction to: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
Mol Cancer; 2020 Aug; 19(1):124. PubMed ID: 32772915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
